Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?

被引：0
|
作者：
N A Do Thi
P Saillour
L Ferrero
T Paunio
J Mallet
机构：
[1] Laboratoire de Genetique Moleculaire de la Neurotransmission et des Processus Neurodegeneratifs,Department of Molecular Medicine
[2] CNRS,undefined
[3] UMR 7091,undefined
[4] Bat. CERVI,undefined
[5] Hopital Pitie-Salpetriere,undefined
[6] Gencell SAS,undefined
[7] Vitry sur Seine,undefined
[8] Biomedicum,undefined
来源：
Gene Therapy | 2007年 / 14卷
关键词：
adenoviral vector; Parkinson's disease; Glial cell line-derived neurotrophic factor; NSE promoter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The transfer of the Glial cell line-derived neurotrophic factor (GDNF) gene to the central nervous system by a recombinant adenoviral vector (Ad) was studied. We constructed the adenovirus vector Ad-NSE-GDNF from which the E1, E3/E4 regions of Ad5 have been deleted and in which the GDNF gene was under the control of a neuron-specific enolase (NSE) promoter. The vector was injected into the striatum of a rat model of Parkinson's disease. We found that (i) the NSE promoter can restrict transgene expression in neurons; (ii) Ad-NSE-GDNF significantly protected dopaminergic (DA) neurons in the substantia nigra (SN) but did not reverse the impairments of amphetamine-induced rotational behavior in lesioned rats.
引用
收藏
页码：441 / 450
页数：9
相关论文
共 50 条
  • [1] Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
    Do Thi, N. A.
    Saillour, P.
    Ferrero, L.
    Paunio, T.
    Mallet, J.
    GENE THERAPY, 2007, 14 (05) : 441 - 450
  • [2] Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease
    Sun, M
    Kong, LX
    Wang, XD
    Lu, XG
    Gao, QS
    Geller, AI
    BRAIN RESEARCH, 2005, 1052 (02) : 119 - 129
  • [3] Statins protect dopaminergic neurons in the mouse model of Parkinson's disease
    Ghosh, A.
    Pahan, K.
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 : 132 - 132
  • [4] Colchicine Protects Dopaminergic Neurons in a Rat Model of Parkinson's Disease
    Salama, Mohamed
    Ellaithy, Amr
    Helmy, Basem
    El-Gamal, Mohamed
    Tantawy, Dina
    Mohamed, Mie
    Sheashaa, Hussein
    Sobh, Mohamed
    Arias-Carrion, Oscar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (07) : 836 - 843
  • [5] Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
    Giuseppa Mudò
    Johanna Mäkelä
    Valentina Di Liberto
    Timofey V. Tselykh
    Melania Olivieri
    Petteri Piepponen
    Ove Eriksson
    Annika Mälkiä
    Alessandra Bonomo
    Minna Kairisalo
    Jose A. Aguirre
    Laura Korhonen
    Natale Belluardo
    Dan Lindholm
    Cellular and Molecular Life Sciences, 2012, 69 : 1153 - 1165
  • [6] Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease
    Mudo, Giuseppa
    Makela, Johanna
    Di Liberto, Valentina
    Tselykh, Timofey V.
    Olivieri, Melania
    Piepponen, Petteri
    Eriksson, Ove
    Malkia, Annika
    Bonomo, Alessandra
    Kairisalo, Minna
    Aguirre, Jose A.
    Korhonen, Laura
    Belluardo, Natale
    Lindholm, Dan
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (07) : 1153 - 1165
  • [7] Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson's Disease
    Yong, Yue
    Ding, Hanqing
    Fan, Zhiqin
    Luo, Jia
    Ke, Zun-Ji
    NEUROCHEMICAL RESEARCH, 2011, 36 (03) : 367 - 374
  • [8] Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson’s Disease
    Yue Yong
    Hanqing Ding
    Zhiqin Fan
    Jia Luo
    Zun-Ji Ke
    Neurochemical Research, 2011, 36 : 367 - 374
  • [9] Does the peroxisome proliferator-activated receptor (PPAR)-alpha agonist fenofibrate protect against dopaminergic neuronal death in a rat model of Parkinson's disease?
    Barbiero, J. K.
    Santiago, R. M.
    Tonin, F. S.
    Boschen, S.
    Motta, L.
    Werner, M. F.
    Da Cunha, C.
    Lima, M. M. S.
    Vital, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S217 - S218
  • [10] Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease
    Zarbakhsh, Sam
    Safari, Manouchehr
    Aldaghi, Mohammad Reza
    Sameni, Hamid Reza
    Ghahari, Laya
    Lagmouj, Younes Khaleghi
    Jaberi, Khojasteh Rahimi
    Parsaie, Houman
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (07) : 722 - 728
12345